Cargando…
Development of Neuroendocrine Prostate Cancers by the Ser/Arg Repetitive Matrix 4-Mediated RNA Splicing Network
While the use of next-generation androgen receptor pathway inhibition (ARPI) therapy has significantly increased the survival of patients with metastatic prostate adenocarcinoma (AdPC), several groups have reported a treatment-resistant mechanism, whereby cancer cells can become androgen receptor (A...
Autores principales: | Lee, Ahn R., Che, Nicole, Lovnicki, Jessica M., Dong, Xuesen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891588/ https://www.ncbi.nlm.nih.gov/pubmed/29666783 http://dx.doi.org/10.3389/fonc.2018.00093 |
Ejemplares similares
-
Alternative RNA splicing of the GIT1 gene is associated with neuroendocrine prostate cancer
por: Lee, Ahn R., et al.
Publicado: (2018) -
Roles of Alternative RNA Splicing of the Bif-1 Gene by SRRM4 During the Development of Treatment-induced Neuroendocrine Prostate Cancer
por: Gan, Yu, et al.
Publicado: (2018) -
Corrigendum to ‘Roles of alternative RNA splicing of the Bif-1 gene by SRRM4 during the development of treatment-induced neuroendocrine prostate cancer’. [EBioMedicine 31 (2018) 267–275>
por: Gan, Yu, et al.
Publicado: (2020) -
Alternative RNA splicing of the MEAF6 gene facilitates neuroendocrine prostate cancer progression
por: Lee, Ahn R., et al.
Publicado: (2017) -
Alternative splicing of LSD1+8a in neuroendocrine prostate cancer is mediated by SRRM4
por: Coleman, Daniel J., et al.
Publicado: (2020)